FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults
Pharmacy Times
JUNE 10, 2025
1 "[Meloxicam injection] demonstrates our commitment to improving patient care by providing an alternate dosage form for pain management," Ron Scarboro, chief executive officer at Azurity Pharmaceuticals, said in a press release. August 24, 2018. 2 REFERENCES 1. 2 REFERENCES 1. Schwenk E, Mariano E, et al. Doi:10.4097/kja.d.18.00217
Let's personalize your content